Region-dependent modulation of intestinal permeability by drug efflux transporters: In vitro studies in mdr1a(-/-) mouse intestine

被引:81
作者
Stephens, RH
Tanianis-Hughes, J
Higgs, NB
Humphrey, M
Warhurst, G
机构
[1] Univ Manchester, Gut Barrier Grp, Salford M6 8HD, Lancs, England
[2] Hope Hosp, Salford Hosp Trust, Salford, Lancs, England
[3] Pfizer Global Res & Dev, Pharmaceut Sci, Sandwich, Kent, England
关键词
D O I
10.1124/jpet.102.041236
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Information on the extent to which xenobiotics interact with P-glycoprotein (PGP) during transit through the intestine is crucial in determining the influence of PGP on oral drug absorption. We have recently described a novel use of isolated ileum from PGP-deficient mdr1a(-/-) mice to resolve PGP- and non-PGP-dependent drug efflux and provide a definitive measure of intrinsic drug permeability without recourse to inhibitors (Stephens et al., 2002). The present study uses this approach to investigate the impact of PGP on intestinal permeability of paclitaxel and digoxin in different regions of the mouse intestine (jejunum, ileum, and proximal and distal colon). Absorption of paclitaxel and digoxin in tissues from wild-type mice was low and showed little regional variation. In contrast, absorption of both drugs was markedly higher in mdr1a(-/-) intestine, although the increase was highly region-dependent, with the ileum and distal colon showing the greatest effect and much smaller changes in the jejunum and proximal colon. These effects were accompanied by the abolition of paclitaxel and digoxin secretion in mdr1a(-/-) mice, suggesting that regional variations in intestinal permeability are masked by differential PGP expression, confirmed by immunoblotting studies. Propranolol permeability, which is not influenced by PGP, showed similar regional variation in both wild-type and mdr1a(-/-) tissues, suggesting that differences are at the level of transcellular permeability. These data suggest that the ileum and the distal colon are regions of relatively high transcellular permeability for xenobiotics that are compensated by enhanced expression of PGP.
引用
收藏
页码:1095 / 1101
页数:7
相关论文
共 38 条
[31]  
Stephens RH, 2001, J PHARMACOL EXP THER, V296, P584
[32]   THE MULTIDRUG RESISTANCE AND CYSTIC-FIBROSIS GENES HAVE COMPLEMENTARY PATTERNS OF EPITHELIAL EXPRESSION [J].
TREZISE, AEO ;
ROMANO, PR ;
GILL, DR ;
HYDE, SC ;
SEPULVEDA, FV ;
BUCHWALD, M ;
HIGGINS, CF .
EMBO JOURNAL, 1992, 11 (12) :4291-4303
[33]   Membrane transport of drugs in different regions of the intestinal tract of the rat [J].
Ungell, AL ;
Nylander, S ;
Bergstrand, S ;
Sjöberg, Å ;
Lennernäs, H .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1998, 87 (03) :360-366
[34]   Intestinal permeability and contractility in murine colitis [J].
van Meeteren, ME ;
van Bergeijk, JD ;
van Dijk, APM ;
Tak, CJAM ;
Meijssen, MAC ;
Zijlstra, FJ .
MEDIATORS OF INFLAMMATION, 1998, 7 (03) :163-168
[35]   Transport of the cooked-food mutagen 2-amino-1-methyl-6-phenylimidazo-[4,5-b]pyridine (PhIP) across the human intestinal Caco-2 cell monolayer:: role of efflux pumps [J].
Walle, UK ;
Walle, T .
CARCINOGENESIS, 1999, 20 (11) :2153-2157
[36]   Somatostatin receptor subtype 2 mediates somatostatin inhibition of ion secretion in rat distal colon [J].
Warhurst, G ;
Higgs, NB ;
Fakhoury, H ;
Warhurst, AC ;
Garde, J ;
Coy, DH .
GASTROENTEROLOGY, 1996, 111 (02) :325-333
[37]   Colon-specific drug delivery: new approaches and in vitro/in vivo evaluation [J].
Yang, LB ;
Chu, JS ;
Fix, JA .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 235 (1-2) :1-15
[38]  
Yumoto R, 1999, J PHARMACOL EXP THER, V289, P149